Antihistamine/decongestant regimens for treating rhinitis
US6651816B2 · kind B2 · utility
16Cited by
8References
14Claims
0Family size
Inventor
Key dates
| Filing date | May 4, 2001 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Jun 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61J1/035
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A prepackaged, therapeutic regimen includes a non-sedating first dosage unit that includes a nasal decongestant, a second dosage unit that includes an antihistamine and an attenuated dosage of nasal decongestant, indicia for distinguishing between the first and second dosage units, administration instructions that teach the coordinated use of the first and second dosage units, and a pharmaceutical dispensing container containing the first and second dosage units and incorporating the indicia and coordinating instructions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.